Cell proliferation and subcellular localization of alkaline phosphatase activity in rat liver parenchyma during azo dye carcinogenesis. 1975

S Karasaki

A combined method of phosphatase histochemistry and (3H)thymidine radioautography was devised to study the subcellular localization of alkaline phosphatase (AP) activiity with changing pattern of cell proliferation in precancerous livers of rats fed dimethylaminoazobenzene. After 50 hr of continuous infusion of (3H)thymidine into the rats, labeled liver tissue were fixed in glutaraldehyde. Sections were incubated for AP activity in a lead citrate medium (pH 9.4) with beta-glycerophosphate as substrate. Light and electron microscopic examinations of radioautographs revealed that focal groups of 3H-labeled hepatocytes within hyperplastic nodules were coincident to hyperbasophilic foci and distinguishable from the surrounding parenchyma, which was sparsely labeled. Proliferative hepatocytes in the foci exhibited enzyme reaction product indicative of AP activity along the entire surface membranes. The surface AP tography was in contrast to that of the surrounding hyperplastic parencyma, in which regenerative hepatocytes showed a normal localization of AP activity at the bile canalicular membranes. The L-phenylalanine-sensitive snd heat-resistant activity of hyperbasophilic hepatocytes was different from that of normal hepatocytes. The surface enzyme differentiation was accompanied by a decrease of cytoplasmic AP. Golgi elements apparently function in the mobilization of AP into the surface membranes. The phenomena of AP alterations might be related to the abnormal control of cell proliferation and cytodifferentiation leading to malignant growth.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008297 Male Males
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D011230 Precancerous Conditions Pathological conditions that tend eventually to become malignant. Preneoplastic Conditions,Condition, Preneoplastic,Conditions, Preneoplastic,Preneoplastic Condition,Condition, Precancerous,Conditions, Precancerous,Precancerous Condition
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D003593 Cytoplasm The part of a cell that contains the CYTOSOL and small structures excluding the CELL NUCLEUS; MITOCHONDRIA; and large VACUOLES. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Protoplasm,Cytoplasms,Protoplasms
D004124 p-Dimethylaminoazobenzene A reagent used mainly to induce experimental liver cancer. According to the Fourth Annual Report on Carcinogens (NTP 85-002, p. 89) published in 1985, this compound "may reasonably be anticipated to be a carcinogen." (Merck, 11th ed) Butter Yellow,Dimethylaminoazobenzene,4-Dimethylaminoazobenzene,Methyl Yellow,p-Dimethylaminoazobenzene, (E)-Isomer,p-Dimethylaminoazobenzene, (Z)-Isomer,4 Dimethylaminoazobenzene,p Dimethylaminoazobenzene

Related Publications

S Karasaki
January 1971, Histochemie. Histochemistry. Histochimie,
S Karasaki
March 1961, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
S Karasaki
January 1963, Acta - Unio Internationalis Contra Cancrum,
S Karasaki
July 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
S Karasaki
January 1971, Histochemie. Histochemistry. Histochimie,
Copied contents to your clipboard!